Article

Figures for Interest Grows in Treatment of Mood Disorders by Classic Psychedelics

Author(s):

Nicole Ledwos, MSc,M. Ishrat Husain, MD (Res), MBBS, MRCPsych

This is the extra table for "Interest Grows in Treatment of Mood Disorders by Classic Psychedelics."

Table. Registered Clinical Trials on ClinicalTrials.gov

Table. Registered Clinical Trials on ClinicalTrials.gov

Related Videos
Related Content
lithium
November 14th 2024

Exploring the Antisuicidal Effects of Lithium

Jesse Woo, MD Haley Schuster, MD Mark Mullen, MD Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
cognitive impairment
November 4th 2024

Addressing Sleep Disturbances Associated With Cognitive Impairment

Leah Kuntz
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
ketamine
October 30th 2024

Psychiatrists Utilizing Ketamine-Assisted Psychotherapy

Miriam Schultz, MD
ketamine
October 4th 2024

Doing It Together: Ketamine-Assisted Psychotherapy in a Small Group

Dinah Miller, MD
© 2024 MJH Life Sciences

All rights reserved.